SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: chirodoc who wrote (240)11/21/1997 9:48:00 AM
From: scott harrison  Read Replies (1) | Respond to of 887
 
chirodoc: <makes this one of the SAFER sectors--the street is bidding up pharmas, and watching bios carefully. .......can you imagine biotech being safe? what a concept!> as one of many who thought Anesta was safe, there is very little "Safety" with these smaller biotechs. Approval will add a safety net, but DEPO is no Bristol Myers or Lilly. be careful and realize you are in a company where things beyond your control (FDA guy on vacation, wife splits up with him, etc - can seriously damage you. Of course I doubt with approval anyone will lose money, but god forbid ... scott



To: chirodoc who wrote (240)11/21/1997 9:59:00 AM
From: scott harrison  Read Replies (3) | Respond to of 887
 
anyone thing this FDA overhaul will affect our price at all? I'd think it'd be a positive little boost for all drug companies. scott


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News